1. Home
  2. RNXT vs CIIT Comparison

RNXT vs CIIT Comparison

Compare RNXT & CIIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • CIIT
  • Stock Information
  • Founded
  • RNXT 2012
  • CIIT N/A
  • Country
  • RNXT United States
  • CIIT Hong Kong
  • Employees
  • RNXT N/A
  • CIIT N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • CIIT
  • Sector
  • RNXT Health Care
  • CIIT
  • Exchange
  • RNXT Nasdaq
  • CIIT NYSE
  • Market Cap
  • RNXT 44.6M
  • CIIT 36.0M
  • IPO Year
  • RNXT 2021
  • CIIT N/A
  • Fundamental
  • Price
  • RNXT $1.30
  • CIIT $1.23
  • Analyst Decision
  • RNXT Strong Buy
  • CIIT
  • Analyst Count
  • RNXT 2
  • CIIT 0
  • Target Price
  • RNXT $7.25
  • CIIT N/A
  • AVG Volume (30 Days)
  • RNXT 135.9K
  • CIIT 312.1K
  • Earning Date
  • RNXT 08-12-2025
  • CIIT 06-09-2025
  • Dividend Yield
  • RNXT N/A
  • CIIT N/A
  • EPS Growth
  • RNXT N/A
  • CIIT N/A
  • EPS
  • RNXT N/A
  • CIIT N/A
  • Revenue
  • RNXT $240,000.00
  • CIIT $9,464,501.00
  • Revenue This Year
  • RNXT $3,104.65
  • CIIT N/A
  • Revenue Next Year
  • RNXT $301.89
  • CIIT N/A
  • P/E Ratio
  • RNXT N/A
  • CIIT N/A
  • Revenue Growth
  • RNXT N/A
  • CIIT 51.52
  • 52 Week Low
  • RNXT $0.75
  • CIIT $0.56
  • 52 Week High
  • RNXT $1.69
  • CIIT $5.38
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 53.41
  • CIIT N/A
  • Support Level
  • RNXT $1.29
  • CIIT N/A
  • Resistance Level
  • RNXT $1.38
  • CIIT N/A
  • Average True Range (ATR)
  • RNXT 0.07
  • CIIT 0.00
  • MACD
  • RNXT -0.01
  • CIIT 0.00
  • Stochastic Oscillator
  • RNXT 48.39
  • CIIT 0.00

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About CIIT TIANCI INTERNATIONAL INC

Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.

Share on Social Networks: